Ozempic, Wegovy, and Their Promise for Treating Alcohol-Use Disorder
By Carolyn Cao ’28
Over the past few years, Ozempic and Wegovy have become incredibly popular, being used as a “short-cut” for weight loss with prominent public figures like Elon Musk and Andy Cohen promoting it. Though Ozempic and Wegovy were originally created to help treat type 2 diabetes and obesity, new studies indicate that there may be some unintended positive benefits; both may reduce alcohol cravings in people with Alcohol Use Disorder, or AUD.
Ozempic and Wegovy work via their active ingredient, semaglutide, which is highly similar to natural hormone GLP-1, having over 90% sequence homology. (GLP-1 regulates appetite and insulin production in the body.) Due to this structural similarity, semaglutide functions in the human body just like GLP-1: it acts as a GLP-1 ...